Clinical trials for Lymphoma

93 currently recruiting clinical trials

Phase 1 / Phase 2 Lymphoma CLL & Richter's syndrome #NCT06564038 #2024-515034-33-00
Required histologic types
B cell lymphoma CLL (Chronic Lymphocytic Leukemia)
Required histologic sub types
Lymphocytic lymphoma
Required number of previous lines of therapy
1 2 3 or more
Required previous treatments
Targeted therapy
Excluded previous treatments
Systemic Treatment-Naive
4 recruiting sites
AstraZeneca
Phase 1 / Phase 2 Lymphoma #NCT06564038 #2024-515034-33-00
Required histologic types
B cell lymphoma
Required histologic sub types
Mantel cell lymphoma Follicular lymphoma Marginal zone lymphoma MALT lymphoma Lymphocytic lymphoma Indolent transformed lymphoma
Required number of previous lines of therapy
1 2 3 or more
Excluded previous treatments
Systemic Treatment-Naive
4 recruiting sites
AstraZeneca
Phase 1 / Phase 2 Lymphoma #NCT06564038 #2024-515034-33-00
Required histologic types
B cell lymphoma
Required histologic sub types
Large B cell lymphoma
Required number of previous lines of therapy
None
4 recruiting sites
AstraZeneca
Phase 1 / Phase 2 Lymphoma #NCT06564038 #2024-515034-33-00
Required histologic types
B cell lymphoma
Required histologic sub types
Mantel cell lymphoma
Required disease stage
Early (stage I and II) Disseminated (stage III and IV)
Required number of previous lines of therapy
2 3 or more
Required previous treatments
Targeted therapy
Excluded previous treatments
Systemic Treatment-Naive
4 recruiting sites
AstraZeneca
Phase 1 / Phase 2 Lymphoma CLL & Richter's syndrome #NCT06564038 #2024-515034-33-00
Required histologic types
B cell lymphoma CLL (Chronic Lymphocytic Leukemia)
Required histologic sub types
Lymphocytic lymphoma
Required number of previous lines of therapy
2 3 or more
Excluded previous treatments
Systemic Treatment-Naive
4 recruiting sites
AstraZeneca
Phase 1 / Phase 2 Lymphoma #NCT06137144
Required histologic types
Hodgkin lymphoma
Required disease stage
Disseminated (stage III and IV)
Required number of previous lines of therapy
None
Required previous treatments
Chemotherapy
3 recruiting sites
AstraZeneca
Phase 1 / Phase 2 Lymphoma #NCT06137144
Required histologic types
Hodgkin lymphoma
Required number of previous lines of therapy
1 2 3 or more
Excluded previous treatments
Systemic Treatment-Naive
3 recruiting sites
AstraZeneca
Phase 1 / Phase 2 Lymphoma #NCT06137144
Required histologic types
T cell lymphoma
Required histologic sub types
Peripheral T cell lymphoma
Required disease stage
Disseminated (stage III and IV)
Required number of previous lines of therapy
1 2 3 or more
Excluded previous treatments
Systemic Treatment-Naive
3 recruiting sites
AstraZeneca
Phase 1 / Phase 2 Lymphoma #NCT06137144
Required histologic types
Hodgkin lymphoma
Required number of previous lines of therapy
2 3 or more
Excluded previous treatments
Systemic Treatment-Naive
3 recruiting sites
AstraZeneca
Phase 1 / Phase 2 Lymphoma #NCT05475925
Required histologic types
T cell lymphoma
Required histologic sub types
Peripheral T cell lymphoma Cutaneous T-cell lymphoma
Required disease stage
Disseminated (stage III and IV)
Required central nervous system lesions
None Treated / Controled
Required number of previous lines of therapy
1 2 3 or more
Excluded previous treatments
Systemic Treatment-Naive
3 recruiting sites
Dren Bio